NRX Pharmaceuticals (NRXP) Current Taxes (2018 - 2020)
NRX Pharmaceuticals (NRXP) posted quarterly Current Taxes of $3145.0 for Q1 2020, down 93.45% year-over-year from $48027.0 in Q2 2019, and down 96.99% quarter-over-quarter from $104439.0 in Q3 2019.
NRX Pharmaceuticals (NRXP) Current Taxes (2018 - 2020) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Current Taxes for 3 consecutive years, with $3145.0 the latest figure, recorded in Q1 2020.
- In Q1 2020, Current Taxes fell 93.45% year-over-year to $3145.0; the TTM figure through Mar 2020 stood at $3145.0 (down 93.45% YoY), while the FY2018 annual figure was $16311.0, changed N/A from the prior year.
- Current Taxes eased to $3145.0 in Q1 2020 per NRXP's latest filing, from $104439.0 in the prior quarter.
- Across five years, Current Taxes topped out at $104439.0 in Q3 2019 and bottomed at $3145.0 in Q1 2020.
- Historically, Current Taxes has averaged $40731.9 across 3 years, with a median of $32169.0 in 2018.
- Annual changes were most pronounced in 2019 — Current Taxes jumped 1067.12% — and 2020, when it sank 93.45%.
- NRX Pharmaceuticals' Current Taxes stood at $16311.0 in 2018, then surged by 540.3% to $104439.0 in 2019, then slumped by 96.99% to $3145.0 in 2020.
- Business Quant data shows NRXP's Current Taxes at $3145.0 in Q1 2020, $104439.0 in Q3 2019, and $88703.0 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | - |
| 10 | NRX Pharmaceuticals | 134.33 Mn | 107.63 Mn | 426,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 3,145.00 |
| Sep 30, 2019 | 104,439.00 |
| Jun 30, 2019 | 88,703.00 |
| Mar 31, 2019 | 48,027.00 |
| Dec 31, 2018 | 16,311.00 |
| Sep 30, 2018 | 48,052.00 |
| Jun 30, 2018 | 13,063.00 |
| Mar 31, 2018 | 4,115.00 |